Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Donohue

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|May 4, 2005
Still looking for answers in COPDJames F Donohue
American Journal of Respiratory and Critical Care Medicine|October 31, 2015
Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects. The FLIGHT StudyJames F Donohue
Chest|August 11, 2004
Therapeutic responses in asthma and COPD. BronchodilatorsJames F Donohue
Proceedings of the American Thoracic Society|November 4, 2005
Combination therapy for chronic obstructive pulmonary disease: clinical aspectsJames F Donohue
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2014
Systematic review comparing LABA, olodaterol, and indacaterol: limitationsJames F Donohue
Respiratory Medicine|December 23, 2015
Response to Letter to the Editor: Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbationsJames F Donohue
The New England Journal of Medicine|May 17, 2016
Another Choice for Prevention of COPD ExacerbationsJames F Donohue
Respiratory Care|April 23, 2008
Safety and efficacy of beta agonistsJames F Donohue
COPD|December 2, 2006
Minimal clinically important differences in COPD lung functionJames F Donohue
Respiratory Medicine|April 23, 2013
Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation ratesJames F Donohue, Neal Jain
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|May 4, 2005
Still looking for answers in COPDJames F Donohue
American Journal of Respiratory and Critical Care Medicine|October 31, 2015
Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects. The FLIGHT StudyJames F Donohue
Chest|August 11, 2004
Therapeutic responses in asthma and COPD. BronchodilatorsJames F Donohue
Proceedings of the American Thoracic Society|November 4, 2005
Combination therapy for chronic obstructive pulmonary disease: clinical aspectsJames F Donohue
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2014
Systematic review comparing LABA, olodaterol, and indacaterol: limitationsJames F Donohue
Respiratory Medicine|December 23, 2015
Response to Letter to the Editor: Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbationsJames F Donohue
The New England Journal of Medicine|May 17, 2016
Another Choice for Prevention of COPD ExacerbationsJames F Donohue
Respiratory Care|April 23, 2008
Safety and efficacy of beta agonistsJames F Donohue
COPD|December 2, 2006
Minimal clinically important differences in COPD lung functionJames F Donohue
Respiratory Medicine|April 23, 2013
Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation ratesJames F Donohue, Neal Jain
Pageof 13